Global Needle-Free Drug Delivery Market 2017-2021
About Needle Free Drug Delivery
Needle free drug delivery technologies are used to deliver biologics such as insulin, vaccines, human growth hormone (HGH), and drugs for pain management into the patient’s body without using a traditional needle. Needle free drug delivery market includes jet injectors, transdermal drug delivery systems and other novel needle free devices that are used as alternatives to conventional needle drug delivery devices.
Technavio’s analysts forecast the global needle free drug delivery market to grow at a CAGR of 10.31% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global needle free drug delivery market for 2017-2021. To calculate the market size, the report considers sales and value.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Needle-Free Drug Delivery Market 2017-2021
Technavio recognizes the following companies as the key players in the global needle-free drug delivery market: Endo Pharmaceuticals, Antares Pharma, Inovio Pharmaceuticals, Valeritas, and PharmaJet.
Other Prominent Vendors in the market are: 3M, Akra Dermojet, Consort Medical, CROSSJECT, Injex Pharma (acquired by Hangzhou Hema Medical Equipment), PenJet Corporation, Zosano, D’Antonio Consultants International, and European Pharma Group.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increasing outsourcing. Companies are outsourcing secondary processes such as manufacturing, logistics, and sterilization to third parties to cut down costs and focus on improving their core product offerings. Many companies such as PharmaJet and Antares Pharma have outsourced their manufacturing operations to third parties.”
According to the report, one driver in the market is increasing incidence of needle stick injuries. According to CDC estimates 12 billion injections are administered annually worldwide. Unsafe injections are resulting in large proportion of bloodborne disease transmission. The percentage of unsafe injections range from 15% in Eastern Europe to 50% in Asia. The contaminated and unsafe needle injections are causing millions of deaths and disability-adjusted life years in healthcare settings.
Further, the report states that one challenge in the market is technical complexities of needle free drug delivery devices. Operating first-generation needle free systems is a complex process compared with standard needle-based systems. The patients must load the spring or prepare the gas reservoir before filling the drug into the cartridge in the autoinjector. Hence, users might need to undergo a moderate level of training, which can be time-consuming.
Endo Pharmaceuticals, Antares Pharma, Inovio Pharmaceuticals, Valeritas, PharmaJet, 3M, Akra Dermojet, Consort Medical, CROSSJECT, Injex Pharma (acquired by Hangzhou Hema Medical Equipment), PenJet Corporation, Zosano, D’Antonio Consultants International, and European Pharma Group.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook